CapsoVision, Inc. (NASDAQ:CV) Sees Significant Increase in Short Interest
by Teresa Graham · The Cerbat GemCapsoVision, Inc. (NASDAQ:CV – Get Free Report) was the recipient of a significant increase in short interest in March. As of March 31st, there was short interest totaling 1,244,098 shares, an increase of 124.8% from the March 15th total of 553,348 shares. Currently, 2.5% of the shares of the stock are sold short. Based on an average daily trading volume, of 815,476 shares, the short-interest ratio is currently 1.5 days.
Wall Street Analyst Weigh In
CV has been the topic of a number of research analyst reports. Weiss Ratings reissued a “sell (e)” rating on shares of CapsoVision in a report on Monday, December 29th. Wall Street Zen raised shares of CapsoVision to a “hold” rating in a report on Saturday, January 10th. Finally, Benchmark decreased their price objective on shares of CapsoVision from $14.00 to $10.00 and set a “speculative buy” rating on the stock in a report on Friday, March 27th. One research analyst has rated the stock with a Strong Buy rating, one has given a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, CapsoVision has a consensus rating of “Moderate Buy” and an average price target of $8.50.
Institutional Trading of CapsoVision
Several institutional investors and hedge funds have recently modified their holdings of the business. Geode Capital Management LLC lifted its holdings in shares of CapsoVision by 34.1% in the fourth quarter. Geode Capital Management LLC now owns 154,264 shares of the company’s stock valued at $1,649,000 after purchasing an additional 39,231 shares in the last quarter. State Street Corp lifted its holdings in shares of CapsoVision by 340.7% in the fourth quarter. State Street Corp now owns 85,929 shares of the company’s stock valued at $919,000 after purchasing an additional 66,429 shares in the last quarter. Citadel Advisors LLC purchased a new stake in shares of CapsoVision in the third quarter valued at about $115,000. Millennium Management LLC purchased a new stake in shares of CapsoVision in the fourth quarter valued at about $163,000. Finally, Virtu Financial LLC purchased a new stake in shares of CapsoVision in the fourth quarter valued at about $128,000.
CapsoVision Price Performance
Shares of NASDAQ CV traded down $0.13 on Friday, hitting $6.25. The company’s stock had a trading volume of 91,142 shares, compared to its average volume of 553,105. CapsoVision has a 12-month low of $3.43 and a 12-month high of $15.37. The company has a market capitalization of $311.50 million and a price-to-earnings ratio of -2.85. The stock has a 50 day moving average of $5.78 and a 200-day moving average of $6.44.
CapsoVision (NASDAQ:CV – Get Free Report) last announced its quarterly earnings results on Thursday, March 26th. The company reported $0.02 earnings per share (EPS) for the quarter. The business had revenue of $3.92 million during the quarter.
About CapsoVision
CapsoVision, Inc (NASDAQ: CV) is a medical device company specializing in advanced capsule endoscopy systems for gastrointestinal diagnostics. The company’s flagship product, the CapsoCam® Plus System, features a swallowable, tether-free capsule equipped with four side-viewing cameras that capture high-resolution, 360-degree images of the small intestine. By storing images internally rather than transmitting data wirelessly, CapsoCam Plus enables patients to maintain normal daily activities during the procedure and reduces the risk of signal loss or image drop-out.
In addition to its capsule hardware, CapsoVision offers CapsoCloud®, a secure, cloud-based platform that streamlines image retrieval, storage and reporting.